00:21:52 Don Weinberger: Mhm
This dual action improves metabolic health on several fronts blood sugar regulation, insulin sensitivity, and fat reduction and each of those improvements reduces the bodys inflammatory burden
The TRANSCEND-T2D-1 trial results show that the highest dose (12 mg) achieved a mean A1C reduction of 2.0% and an average body weight reduction of 16.8% at 40 weeks
"I worked with a health coach and a fitness coach and nothing was help[ing] me lose the last 20 pounds." After her sister-in-law found weight-loss success via Wegovy, Oliviara began her own GLP-1 journey, which ended once she found out she was pregnant
Shiraishi, D., Fujiwara, Y., Komohara, Y., Mizuta, H., & Takeya, M